ArticleMicromachines2022
Soliton Microcomb on Chip Integrated
Article in Micromachines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial for the Special Issue on Photonic Chips for Optical Communications.Micromachines · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Soliton microcombs, offering large mode spacing and broad bandwidth, have enabled a variety of advanced applications, particularly for telecommunications, photonic data center, and optical computation. Yet, the absolute power of microcombs remains insufficient, such that optical power amplification is always required. Here, we demonstrate a combined technique to access power-sufficient optical microcombs, with a photonic-integrated soliton microcomb and home-developed erbium-doped gain fiber. The soliton microcomb is generated in an integrated Si3N4 microresonator chip, which serves as a full-wave probing signal for power amplification. After the amplification, more than 40 comb modes, with 115-GHz spacing, reach the onset power level of >−10 dBm, which is readily available for parallel telecommunications , among other applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.